Mr. George Reznik reports

LIGHT AI RESPONDS TO OTC MARKETS REQUEST ON RECENT PROMOTIONAL ACTIVITY

Light AI Inc. has been requested by OTC Markets Group Inc. to issue this statement about promotional activity concerning its common shares traded on the OTCQB Venture Market (operated by OTC Markets).

On May 7, 2025, OTC Markets informed the company that it became aware of certain promotional activities concerning the company and its shares traded on the OTCQB, including the distribution of one newsletter and one stock alert post published by Emerging Markets Consulting LLC, discussing the company, its business, the economy and the health care artificial intelligence market generally.

On Jan. 14, 2025, the company entered into an advertising agreement with Emerging Markets, whereby Emerging Markets would provide investor relations and advertising services to the company. The company was therefore aware of Emerging Market's promotional activities respecting the company since Jan. 14, 2025. Accordingly, the promotional materials were paid for by the company through its engagement of Emerging Markets.

The engagement of Emerging Markets, the nature of the relationship between the company and Emerging Markets, as well as the compensation paid to Emerging Markets, was publicly disclosed in a news release on Jan. 29, 2025, which can be found under the company's profile on SEDAR+.

The company provided Emerging Markets with publicly available sources of information for its marketing materials, and management reviewed and approved the materials prepared by Emerging Markets prior to their dissemination, including to ensure factual accuracy. The company does not believe the statements in the promotional materials were materially false or misleading. However, the company notes that investing in the company's securities involves certain risks and uncertainties which investors should review prior to making any investment decision. The company encourages all investors to undertake proper due diligence and carefully consider all investment decisions. The company directs potential investors to rely solely on its filings and disclosures made with the Canadian Securities Administrators, available at SEDAR+.

After inquiry of management, other than as disclosed herein, no directors and control persons, its officers, directors or controlling shareholders, or any third party service providers have, directly or indirectly, been involved with the creation, distribution or payment of promotional materials related to the company and its securities.

The company does not believe the promotional activities had any substantial impact on the trading price or volume of the shares.

Except as disclosed below, after inquiry of management, its officers, directors, any controlling shareholders or any third party service providers, the company is not aware of any purchases or sales of the shares in the past 90 days:

• An arm's-length financial advisory consultant sold 569,000 shares and purchased 569,500 shares since Feb. 8, 2025.
• An entity controlled by Gold Standard Media LLC sold 267,000 shares.

The company has engaged the following third party service providers to provide investor relations services, public relations services, marketing or other related service within the past 12 months: Gold Standard Media (Jan. 14, 2025), New Era Publishing Inc. (Jan. 14, 2025), Freedom Financial Resources LLC (Jan. 24, 2025), Senergy Communications Capital Inc. (Jan. 14, 2025), Outside The Box Capital Inc. (Jan. 14, 2025), Capital Gains Media Inc. (Jan. 14, 2025), Entourage Group Inc. (Jan. 14, 2025), Direct To Investor Media LLC (Jan. 14, 2025), Emerging Markets Consulting (Jan. 14, 2025), MIC Market Information & Content Publishing GmbH (Jan. 29, 2025), Bergskogar Ltd. doing business as Scandinavian Alliance (Jan, 14, 2025), Green Stock News LLC (Jan. 24, 2025), ZNEK Holdings Ltd. (Jan. 24, 2025), BW Venture Strategies Inc. (Jan. 27, 2025), Independent Trading Group Inc. (Jan. 24, 2025), and Commodity Partners Inc. (Feb. 14, 2025).

Other than pursuant to financings and acquisition transactions in accordance with Cboe Canada policies, which the company has publicly disclosed in news releases (available at: SEDAR+), including the public offering of shares completed on Jan. 8, 2025, the company has not issued shares or convertible instruments allowing conversion to equity securities, at prices constituting, at the time of issuance of such shares or convertible instruments, at a discount to the then current market price.

About Light AI Inc.

Light AI is a technology company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smart phone images -- starting with images of strep A -- to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind. Its hardware platform is the 4.5 billion smart phones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving health care delivery worldwide. Its cutting-edge AI powered technology offers rapid, accurate and cost-effective diagnostic tools designed to address critical health care challenges.

In pre-Food and Drug Administration validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A streptococcus (GAS). The algorithm achieved a 96.57-per-cent accuracy rate and attained a negative predictive value of 100 per cent, indicating its high reliability in confirming the absence of streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as rheumatic heart disease, which imposes a global economic burden exceeding $1-trillion annually. Light AI's technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI's approach to applying AI to smart phone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI's vision is to combine the smart phone with AI in the cloud to create a digital clinical lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

We seek Safe Harbor.